CHR. OLESEN SYNTHESIS A/S: Financial statements 2015
CVR: 33964870
Source: annual report 2015, Danish Business Authority
01/10/2014 – 30/09/2015
CHR. OLESEN SYNTHESIS A/S (CVR 33964870) has filed annual accounts for 2015. In 2015, the company reported a gross profit of EUR 742,286 and a net result of EUR -1,386,267 compared with EUR -2,004,972 the year before. Equity in the 2015 report amounted to EUR 10,630,042. The solvency ratio was 86.8%.
- Gross Profit
- EUR 742,286
- Profit/Loss
- EUR -1,386,267
- Equity
- EUR 10,630,042
- Total Assets
- EUR 12,253,404
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 742K EUR | -1.4M EUR | 10.6M EUR | - |
| 2014 | - | -166K EUR | -2M EUR | -4.6M EUR | - |
| 2013 | - | -85 EUR | -1.5M EUR | -2.6M EUR | - |
| 2012 | - | -934K | -1.6M | -1.2M | - |
Official annual report
How creditworthy is CHR. OLESEN SYNTHESIS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of October 1, 2015, Tibor Simon has joined the board of directors of CHR. OLESEN SYNTHESIS A/S.
As of September 30, 2015, James Charles Gale has joined the board of directors of CHR. OLESEN SYNTHESIS A/S.
As of September 30, 2015, Svend Aage Johansen has left the board of directors of CHR. OLESEN SYNTHESIS A/S.
CHR. OLESEN SYNTHESIS A/S has published its annual report for 2014. Gross profit came to DKK -165,799, and the net result was DKK -2,004,972.
About CHR. OLESEN SYNTHESIS A/S
CHR. OLESEN SYNTHESIS A/S is a Danish company of the type Aktieselskab based in Hvidovre, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Thomas Michael Moestrup. The board consists of Jean-Francois Hilaire (chair), Joseph Nivaro and Thomas Michael Moestrup. The company is owned by Samfara/Bering Bidco Limited. The company has 97 employees (2026). In 2025, the company reported a gross profit of EUR 6,958,825 and a net result of EUR -2,299,046 compared with EUR 7,391,800 the year before. Equity in the 2025 report amounted to EUR -9,489,900.
